Home > Analytics > TTK HEALTHCARE

TTK HEALTHCARE
Intrinsic Value | Fundamental Analysis

BOM : 507747     NSE : TTKHLTCARE    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 26,2023
Price(EOD): β‚Ή 1,260.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 1,776.81 Cr
Value of β‚Ή 1 Lac invested in TTK HEALTHCARE
on May 28,2018 (price: β‚Ή 946.75)

β‚Ή 1 L

β‚Ή 1.33 L

1W : 1.2% 1M : -0.2% 1Y : 68%
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results
TTK HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
TTK HEALTHCARE 1.2% -0.2% 68%
SUN PHARMACEUTICAL INDUSTRIES 3.6% -0.1% 2.5%
DIVIS LABORATORIES 7.5% 9% -11.9%
CIPLA 2.8% 4.3% -2.7%
DR REDDYS LABORATORIES 1.7% -6.5% 5.3%
TORRENT PHARMACEUTICALS 2% 5% 30%
ABBOTT INDIA 2.5% -1.9% 23%
ZYDUS LIFESCIENCES 0.3% -1.7% 39.6%
ALKEM LABORATORIES 2.8% -2.4% 11.4%

FUNDAMENTAL ANALYSIS OF TTK HEALTHCARE

 
Fundamentals Score
[ Q(TTM): Mar2023, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF TTK HEALTHCARE

 
Valuation Score
[As on : May 26,2023 ]

Ratio Standalone
P/E
P/B
P/S
39.86
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 44.67 Cr
[Latest Qtr - Mar2023 - Standalone Results ]

1.88
P/B Calculated based on Book Value of Rs 948.97 Cr
[Latest Year - Mar2023 - Standalone Results ]

2.46
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2023 - Standalone Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 25% undervalued companies ! Discover More →

FAIR VALUE OF TTK HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
153%
21%
36%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF TTK HEALTHCARE


Insights πŸ’‘ There are 43% companies with bullish price momentum currently! Discover More →

TTK HEALTHCARE vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF TTK HEALTHCARE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.06
0.06
0.12
0.08
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF TTK HEALTHCARE

Pledged Promoter Shares
0 %
As on : Mar2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF TTK HEALTHCARE

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-1.33%
80.14%
64.88%
70.25%
13.53%
224.04%
361.01%
383.45%
QtrlyTrend
6
Latest Qtr: Mar2023
Quarterly Result Analysis →

Insights πŸ’‘ TTKHLTCARE is one of the top 44% companies with good quarterly result uptrend ! Discover More →

TTK HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 2% 6.8% 16.6%
S&P BSE ALLCAP 1.9% 5% 12.9%
S&P BSE SMALL CAP 1.4% 6.3% 14.5%
S&P BSE INDUSTRIALS 1.2% 5.5% 42.4%
No NSE index found

You may also like the below Video Courses


FAQ about TTK HEALTHCARE


Is TTK HEALTHCARE good for long term investment?

As on May 26,2023, the Fundamentals of TTK HEALTHCARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of TTK HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TTK HEALTHCARE UnderValued or OverValued?

As on May 26,2023, TTK HEALTHCARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TTK HEALTHCARE ?

As on May 26,2023, the Intrinsic Value of TTK HEALTHCARE is Rs. 925.44 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 498.76
Fair Value [Median EV / Sales Model] : Rs. 1,041.94
Fair Value [Median Price / Sales Model] : Rs. 925.44
Estimated Median Fair Value of TTK HEALTHCARE : Rs. 925.44

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is TTK HEALTHCARE trading at a Premium or Discount?

As on May 26,2023, TTK HEALTHCARE is trading at a Premium of 36% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].